Speaker Profile
M.D., Senior Vice President, Immunology Development, Eli Lilly &
Biography
Mark C. Genovese, MD, is the SVP for Immunology Development at Eli Lilly and Company overseeing all development endeavors in the areas of Rheumatology, Gastroenterology, Dermatology, Allergy, Respiratory, and incretins in Immunology. Prior to joining Lilly, he served as the SVP for Clinical Development for Inflammation and Fibrosis at Gilead Sciences. Before joining industry, he was the James W. Raitt Professor of Medicine and Clinical Chief of the Division of Immunology and Rheumatology at Stanford University. Dr. Genovese is an author of over 200 peer reviewed articles, editor on the 7th edition of Kelley’s Textbook of Rheumatology.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
